TNON · XBRL financial data
Tenon Medical financial statements, every fiscal year
The same tables from 4 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (TNON's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | †Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|
| Revenue | 691 | 2,928 | 3,277 | 3,944 |
| Cost of revenue | 1,332 | 1,687 | 1,566 | 1,586 |
| Gross profit | (641) | 1,241 | 1,711 | 2,358 |
| Research and development | 2,828 | 3,163 | 2,603 | 2,149 |
| General and administrative | 7,423 | 7,027 | 7,765 | 6,975 |
| Total operating expenses | 18,084 | 16,968 | 15,477 | 15,150 |
| Operating income (loss) | (18,725) | (15,727) | (13,766) | (12,792) |
| Interest expense | 354 | 21 | 34 | — |
| Other income (expense) | (18) | — | (56) | — |
| Net income (loss) | (18,917) | (15,581) | (13,673) | (12,556) |
| Earnings per share, basic USD per share | (2.36) | (8.59) | (11.26) | (1.70) |
| Earnings per share, diluted USD per share | (2.36) | (8.59) | (11.26) | (1.70) |
| Weighted average shares, basic thousands of shares | 8 | 2 | 1 | 7 |
| Weighted average shares, diluted thousands of shares | 8 | 2 | 1 | 7 |
- † Share count changed about 1/3 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 2x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (TNON's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | †Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,129 | 2,428 | 6,535 | 3,756 |
| Short-term investments | 6,441 | — | — | — |
| Accounts receivable | 228 | 518 | 863 | 1,698 |
| Inventory | 415 | 554 | 606 | 1,054 |
| Prepaid and other current assets | — | 389 | 206 | 260 |
| Total current assets | 9,347 | 3,889 | 8,210 | 6,768 |
| Property and equipment, net | 793 | 961 | 752 | 918 |
| Right-of-use asset | 873 | 646 | 399 | 131 |
| Goodwill | — | — | — | 2,407 |
| Total assets | 11,089 | 6,345 | 9,843 | 10,760 |
| Accounts payable | 550 | 433 | 369 | 845 |
| Accrued liabilities | 717 | 808 | 910 | 1,637 |
| Total current liabilities | 2,530 | 3,140 | 1,869 | 3,213 |
| Lease liability, non-current | 683 | 428 | 141 | — |
| Total liabilities | 4,837 | 5,567 | 3,872 | 5,720 |
| Accumulated deficit | (39,492) | (55,073) | (68,746) | (81,302) |
| Total stockholders' equity | 6,252 | 778 | 5,971 | 5,040 |
| Total liabilities and equity | 11,089 | 6,345 | 9,843 | 10,760 |
| Common shares outstanding (cover page) thousands of shares | 11,251 | 3,727 | 5,585 | 11,296 |
- † Share count changed about 1/3 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 2x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (TNON's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | †Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|
| Net income (loss) | (18,917) | (15,581) | (13,673) | (12,556) |
| Stock-based compensation | 2,897 | 4,145 | 3,845 | 1,691 |
| Depreciation and amortization | 78 | 199 | — | — |
| Net cash from operating activities | (12,025) | (12,183) | (9,878) | (10,745) |
| Purchases of property and equipment | 847 | 361 | 186 | 273 |
| Net cash from investing activities | (2,884) | 6,142 | (186) | (1,023) |
| Proceeds from issuing common stock | 14,139 | 4,808 | 2,106 | — |
| Net cash from financing activities | 14,114 | 6,302 | 14,125 | 8,989 |
| Net change in cash | (788) | 299 | 4,107 | (2,779) |
- † Share count changed about 1/3 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 2x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Tenon Medical | 1,677 | 1,279 | (2,758)* | 667,047 | 0.6 quarters | 10-QJun 30, 2026 |
| SeaStar Medical Holding | 6,959 | 615 | (2,994)* | 4.4M | 2.3 quarters | 10-QJun 30, 2026 |
| ENvue Medical | 1,084 | 239 | (2,691)* | 11.1M | 0.4 quarters | 10-QJun 30, 2026 |
| Bone Biologics | 6,088 | not reported | (532)* | 3.4M | 9.8 quarters | 10-QSep 30, 2026 |
| Sintx Technologies | 3,590 | 452 | (2,767)* | 6.7M | 1.3 quarters | 10-QJun 30, 2026 |
| OSR Health | 1,500 | 316 | (2,421)* | 35.1M | 0.6 quarters | 10-QJun 30, 2026 |
| Adm Tronics Unlimited | 223 | not reported | (33) | 67.6M | 6.8 quarters | 10-QJun 30, 2026 |
| Retractable Technologies | 2,641 | 7,201 | (1,732)* | 29.9M | 1.5 quarters | 10-QJun 30, 2026 |
| Sonoma Pharmaceuticals | 5,338 | 6,406 | (649) | 4.8M | 8.2 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.